This document is a slide presentation on aging beautifully with osteoarthritis. It discusses the vision of maintaining joint health and mobility without pain as people age. However, the reality is that osteoarthritis affects over 27 million Americans and causes significant pain and stiffness in joints. The presentation covers education on osteoarthritis, lifestyle modifications like diet and exercise, medications to manage symptoms, and surgery if other options are exhausted. It emphasizes the important role of pharmacists in helping patients effectively manage their osteoarthritis.
2. Aging
Beautifully:
Visions & Realities
Part I: Osteoarthritis
By Christine Hortillosa
Pharm.D. 2013 Candidate
University of Texas at Austin College of Pharmacy
4. 9. 2013
http://www.goodlifeguide.net/wp-content/uploads/2012/09/beach-seniors-X-license.jpg
11. Education
on OA Medications
Diet and
Exercise
Surgery
http://www.clipartguide.com/_named_clipart_images/0511-0905-2016-1540_Old_Man_Walking_with_a_Cane_clipart_image.jpg
Management
12. Medications
Opioids
Topical
Analgesics
APAP
NSAIDS
(types)
PPI
13. Medications
Recommendations for High-Risk Patients
If GI Safety If CV Safety If Renal Safety
is paramount is paramount is paramount
COX-2
inhibitor Naproxen
APAP
PPI PPI
If all else fails, use an OPIOID cautiously.
14. Pharmacists
are critical in
effective
osteoarthritis
management.
http://www.toledoblade.com/image/2012/01/22/800x_b1_cCM_z_cT/pharmacist-bryan-01-23-2012.jpg
15. With your help, I can…
http://www.grandcamp.com/blog/wp-content/uploads/2012/01/at-play-with-grandkids.jpg
16. With your help, I can…
http://lightenupsystems.com/wp-content/uploads/2011/04/Senior-couple-on-the-Beach-Medium.jpg
20. REFERENCES
1. Hunter DJ. Insights from imaging on the epidemiology and pathophysiology of osteoarthritis.
Radiol Clin North Am 2009; 47:539–551.
2. Zhang Y. Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med 2010; 26: 355-369.
3. Harvey WF. Hunter DJ. Pharmacologic intervention for osteoarthritis in older adults. Clin Geriatr
Med 2010; 26: 503-515.
4. Zhang W. Moskowitz RW. Nuki G, et al. OARSI recommendations for the management of hip and
knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage
2008; 16:137–162.
5. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations
for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;
43:1905–1915.
6. Rostom A. Moayyedi P. Hunt R. Canadian Association of Gastroenterology Consensus Group.
Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need
for gastroprotection: Benefits versus risks. Aliment Pharmacol Ther 2009; 29:481–496.
7. Buys LM. Elliott ME. Chapter 101. Osteoarthritis. In: Talbert RL, DiPiro JT, Matzke GR, Posey
LM, Wells BG, Yee GC, eds. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New York: McGraw-Hill;
2011. http://www.accesspharmacy.com/content.aspx?aID=7997482. Accessed April 9, 2013.
8. Pictures throughout the slide deck: see bottom of individual slide.